COVID-19 Vaccine Administration Booster Dose (UB-04 Billing)
Blue Cross and Blue Shield of Kansas (BCBSKS) continues to monitor COVID-19 and the changes with billing new codes. The following new codes will be reimbursed as follows:
|
HCPCS Code |
Nomenclature |
MAP'd like: |
Effective Date |
|
0004A |
IMMUNIZATION ADMINISTRATION BY INTRAMUSCULAR INJECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) (CORONAVIRUS DISEASE [COVID-19]) VACCINE, MRNA-LNP, SPIKE PROTEIN, PRESERVATIVE FREE, 30 MCG/0.3 ML DOSAGE, DILUENT RECONSTITUTED; BOOSTER DOSE |
0001A 0002A 0003A
|
09/03/2021 |
|
0034A |
IMMUNIZATION ADMINISTRATION BY INTRAMUSCULAR INJECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARSCOV-2) (CORONAVIRUS DISEASE [COVID-19]) VACCINE, DNA, SPIKE PROTEIN, ADENOVIRUS TYPE 26 (AD26) VECTOR, PRESERVATIVE FREE, 5X1010 VIRAL PARTICLES/0.5 ML DOSAGE - BOOSTER DOSE |
0001A 0002A 0003A
|
10/20/2021 |
|
0064A |
IMMUNIZATION ADMINISTRATION BY INTRAMUSCULAR INJECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) (CORONAVIRUS DISEASE [COVID-19]) VACCINE, MRNA-LNP, SPIKE PROTEIN, PRESERVATIVE FREE, 50 MCG/0.25 ML DOSAGE, BOOSTER DOSE |
0001A 0002A 0003A
|
09/03/2021 |
|
91306 |
SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) (CORONAVIRUS DISEASE [COVID-19]) VACCINE, MRNA-LNP, SPIKE PROTEIN, PRESERVATIVE FREE, 100 MCG/0.5 ML DOSAGE, FOR INTRAMUSCULAR USE |
91300 91301
|
09/03/2021 |
If you have any questions regarding this newsletter, please contact your BCBSKS Institutional Relations provider consultant.